Chorokbaem Healthcare Co Ltd (118000) - Total Assets
Based on the latest financial reports, Chorokbaem Healthcare Co Ltd (118000) holds total assets worth ₩243.95 Billion KRW (≈ $165.32 Million USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Chorokbaem Healthcare Co Ltd - Total Assets Trend (2013–2025)
This chart illustrates how Chorokbaem Healthcare Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see market value of Chorokbaem Healthcare Co Ltd for the company's overall valuation and market capitalisation.
Chorokbaem Healthcare Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Chorokbaem Healthcare Co Ltd's total assets of ₩243.95 Billion consist of 14.7% current assets and 85.3% non-current assets. Review Chorokbaem Healthcare Co Ltd total liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0.8% |
| Accounts Receivable | ₩11.88 Billion | 6.0% |
| Inventory | ₩1.01 Billion | 0.5% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩12.57 Billion | 6.4% |
| Goodwill | ₩7.50 Billion | 3.8% |
Asset Composition Trend (2013–2025)
This chart illustrates how Chorokbaem Healthcare Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Chorokbaem Healthcare Co Ltd stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Chorokbaem Healthcare Co Ltd's current assets represent 14.7% of total assets in 2025, a decrease from 44.0% in 2013.
- Cash Position: Cash and equivalents constituted 0.8% of total assets in 2025, down from 1.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 46.0% in 2013.
- Asset Diversification: The largest asset category is intangible assets at 6.4% of total assets.
Chorokbaem Healthcare Co Ltd Competitors by Total Assets
Key competitors of Chorokbaem Healthcare Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pfizer Inc
NYSE:PFE
|
USA | $201.13 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $136.46 Billion |
|
Merck & Company Inc
NYSE:MRK
|
USA | $129.80 Billion |
|
AstraZeneca PLC
MX:AZNN
|
Mexico | MX$114.07 Billion |
|
Novartis AG ADR
NYSE:NVS
|
USA | $122.03 Billion |
|
AstraZeneca PLC
F:ZEGA
|
Germany | €114.46 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$201.13 Billion |
|
Biogen Inc
NASDAQ:BIIB
|
USA | $32.09 Billion |
Chorokbaem Healthcare Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.48 | 2.67 | 0.91 |
| Quick Ratio | 0.48 | 2.57 | 0.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩-52.88 Billion | ₩15.24 Billion | ₩-4.90 Billion |
Chorokbaem Healthcare Co Ltd - Advanced Valuation Insights
This section examines the relationship between Chorokbaem Healthcare Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.19 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 25.4% |
| Total Assets | ₩197.96 Billion |
| Market Capitalization | $14.98 Million USD |
Valuation Analysis
Below Book Valuation: The market values Chorokbaem Healthcare Co Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Chorokbaem Healthcare Co Ltd's assets grew by 25.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Chorokbaem Healthcare Co Ltd (2013–2025)
The table below shows the annual total assets of Chorokbaem Healthcare Co Ltd from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | ₩197.96 Billion ≈ $134.16 Million |
+25.44% |
| 2024-12-31 | ₩157.82 Billion ≈ $106.95 Million |
+1.62% |
| 2023-12-31 | ₩155.30 Billion ≈ $105.25 Million |
-18.20% |
| 2022-12-31 | ₩189.86 Billion ≈ $128.66 Million |
+7.69% |
| 2021-12-31 | ₩176.30 Billion ≈ $119.48 Million |
+27.49% |
| 2020-12-31 | ₩138.29 Billion ≈ $93.72 Million |
+98.11% |
| 2019-12-31 | ₩69.80 Billion ≈ $47.31 Million |
+13.61% |
| 2018-12-31 | ₩61.44 Billion ≈ $41.64 Million |
+67.22% |
| 2017-12-31 | ₩36.74 Billion ≈ $24.90 Million |
+27.38% |
| 2016-12-31 | ₩28.84 Billion ≈ $19.55 Million |
+75.83% |
| 2015-12-31 | ₩16.41 Billion ≈ $11.12 Million |
-16.61% |
| 2014-12-31 | ₩19.67 Billion ≈ $13.33 Million |
-10.45% |
| 2013-12-31 | ₩21.97 Billion ≈ $14.89 Million |
-- |
About Chorokbaem Healthcare Co Ltd
METACARE CO., Ltd. distributes pharmaceuticals and medical devices in South Korea. The company sells orthopedic medical devices and consumables; and provides pharmaceutical integration and professional logistics services. It is involved in investment advisory. The company was formerly known as SMEDI Co., Ltd. and changed its name to METACARE CO., Ltd. in August 2024. METACARE CO., Ltd. was founde… Read more